Borrowing a page from his Groupon playbook, Groupon co-founder Eric Lefkofsky has raised another $200 million USD in funding in his new startyo Tempus – bringing the company’s valuation to $3.1 billion USD.
Why this matters: Tempus has built a platform to collect, structure and analyze the clinical data that’s often unorganized in electronic medical record systems. The company also generates genomic data by sequencing patient DNA and other information in its lab. According to Lefkofsky, the goal is to help doctors create customized treatments for each individual patient.
Go on…: Investors in this recent round include Baillie Gifford; Revolution Growth; New Enterprise Associates; funds and accounts managed by T. Rowe Price; Novo Holdings; and the investment management company Franklin Templeton.